Why did TMD.TO stock spike today?

The intraday spike to **C$1.13** came without a confirmed earnings release. Heavy volume and a low prior price suggest speculative buying, short covering, or a block trade. Check Titan Medical’s investor page and regulatory filings for confirmation.

What is Meyka AI’s view on TMD.TO stock?

Meyka AI rates TMD.TO with a score of **68.53/100** (Grade B, Suggestion: HOLD). The model offers a 12-month base fair value **C$0.90** and a bullish target **C$2.50**. These are projections, not guarantees.

Is TMD.TO stock a good trade for intraday traders?

TMD.TO stock shows high volatility and **2.55x** relative volume. Intraday traders can profit on momentum but must manage large spreads and execution risk. Use limit orders and tight stops on TSX trades.

What financials should investors check for TMD.TO stock?

Focus on EPS (reported **-1.73**), cash position, outstanding shares (**114,040,000**) and upcoming filings. Confirm updates on product commercialization and financing which materially affect valuation.

CA Stocks

TMD.TO Titan Medical Inc. (TSX) jumps to C$1.13 on heavy volume 23 Mar 2026: assess catalysts

ByDanny Kontos March 23, 2026

Shares of Titan Medical Inc. (TMD.TO) are trading sharply higher intraday after a sudden surge to C$1.13, up from a previous close of C$0.05, on unusually heavy volume. This move puts TMD.TO stock well above its 50-day average of C$0.07 and 200-day average of C$0.07. Volume hit 117,220 shares versus an average of 45,936, a clear high-volume mover signal for TSX traders in Canada. Below we break down intraday drivers, valuation quirks, technicals, the Meyka AI grade, and a modeled price forecast to frame trading decisions.